St. Radegund, Austria

Manfred Windisch

USPTO Granted Patents = 3 

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2011-2024

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Manfred Windisch: Innovator in Pharmaceutical Chemistry

Introduction

Manfred Windisch is a notable inventor based in St. Radegund, Austria. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel crystalline forms of compounds that act as muscarinic acetylcholine receptor agonists. With a total of three patents to his name, Windisch's work has implications for the treatment of various diseases and disorders.

Latest Patents

Windisch's latest patents focus on crystalline polymorphs of a spiro-compound that serves as a muscarinic acetylcholine receptor agonist. These patents describe isolated crystalline polymorphs of (S)-2-ethyl-8-methyl-1-thia-4,8-diazaspiro[4.5]decane-3-one, which exhibit favorable properties for pharmaceutical manufacturing. The patents also detail methods for preparing these crystalline polymorphs, converting them into one another, and formulating medicaments suitable for treating conditions responsive to muscarinic acetylcholine receptor modulation.

Career Highlights

Throughout his career, Windisch has worked with various companies, including Nsc Therapeutics GmbH and Jsw-Research Forschungslabor GmbH. His experience in these organizations has allowed him to refine his expertise in pharmaceutical research and development.

Collaborations

Windisch has collaborated with notable professionals in his field, including Abraham Fisher and Nira Bar-Ner. These collaborations have contributed to the advancement of his research and the successful development of his patented inventions.

Conclusion

Manfred Windisch is a distinguished inventor whose work in pharmaceutical chemistry has led to innovative solutions for medical treatments. His contributions through patents and collaborations highlight his commitment to advancing the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…